About Charles Henry, MD

Dr. Henry is a child, adolescent, and adult psychiatrist who specializes in the treatment of patients with developmental disorders.  After completing his training in 2001 at the Cambridge Hospital Child Fellowship Program, he joined the faculty at MGH and HMS.

Over the last ten years, Dr. Henry conducted research and provided clinical care for children with autism.  He is frequently consulted on the psychopharmacologic treatment of these patients and has participated nationally in the development of evidence-based guidelines for the management of symptoms associated with autism. 

Dr. Henry provides services at the MGH Child Psychiatry Outpatient Clinic where he supervises residents emphasizing both psychopharmacologic and psychodynamic perspectives with a particular emphasis on the understanding of parental limit setting failures in children with disruptive behavior disorders.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Psychiatry Department
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-5600

Medical Education

  • MD, Northwestern University Medical School
  • Residency, Beth Israel Deaconess Medical Center
  • Residency, Boston Children's Hospital
  • Residency, Brigham and Women's Hospital
  • Residency, North Suffolk Mental Health Association
  • Residency, Shriners Burn Hospital
  • Fellowship, Cambridge Health Alliance

American Board Certifications

  • Psychiatry, American Board of Psychiatry and Neurology
  • Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

In addition to providing clinical care, administrative oversight, and teaching, Dr. Henry has conducted clinical research on the psychopharmacology of autism.  He has received funding from the Casa Colina Foundation that has supported investigations on the effectiveness of serotonin reuptake inhibitors in autistic children.  He has also participated in multicenter clinical trials investigating the effects of aripiprazole on irritability in these patients.  During his child fellowship, Dr. Henry was granted a Livingston Award through HMS to examine self-awareness and neurocognitive measures in schizophrenic patients being treated with olanzapine.  Research funding has resulted in multiple first-author publications and abstract presentations.

Publications